Friday, February 14, 2014

          Patent Trolling: Why Bio & Pharmaceuticals Are at Risk

          Groundbreaking study by Professor Robin Feldman and Harvard Fellow Dr. Nicholson Price show conventional wisdom is wrong when it comes to patent trolls, bio and pharma.
          Sample alt tag.
          Robin Feldman, Professor of Law and Director, Institute for Innovation Law

          Conventional wisdom holds that bio and pharma are safe from patent trolls. In a ground-breaking study, Professor Robin Feldman and Harvard Fellow Dr. Nicholson Price show that the conventional wisdom is wrong.

          The study is available for download via SSRN: Patent Trolling: Why Bio & Pharmaceuticals Are at Risk. Highlights include:

          • With the Association of University Technology Managers revisiting its policy against selling to NPEs, the authors considered whether universities could provide an extensive pool of ammunition for NPEs to launch against current products.
          • To supplement increasing anecdotal evidence that patent trolling is moving into bio and pharma, the authors examined the life science holdings of five major universities.We skimmed the patent holdings for four of the of five university systems with the highest number of patents issued in fiscal year 2011: the University of California system, the University of Texas system, MIT, and CalTech. We added as a wild-card the University of South Florida, the school among the top 10 in 2011 patent grants which had the lowest ratio of license revenues to research expenditures. 
          • The study identified dozens of patents that could be deployed against current bio and pharm industries, following the patterns that NPEs have used against other industries. These include patents on drug formulas, methods of treatments, research methods, dosage forms, and others.
          • In deciding whether to undertake the study, the authors agonized over whether the potential for harm outweighed the potential benefit. After all, if reform efforts are not undertaken, the work could simply provide a handy road map for those who would follow.
          • Life sciences trolling is predictable and in its infancy, however. The study is intended to sound a warning bell.

          About the Instititute for Innovation Law at UC Hastings

          The Institute for Innovation Law (Institute) is a public interest academic center at UC Hastings. The Institute engages in academic research and education to encourage innovation through the practice and development of law and policy. The Institute’s mission is to identify and promote the tools, knowledge, and skills needed to encourage innovation through the practice and development of law and policy.

          Media Contact

          Alex A.G. Shapiro
          Director, Communications & Public Affairs
          UC Hastings College of the Law
          Office: (415) 581-8842
          Cell: (415) 813-9214
          Email: shapiroa@uchastings.edu

          Go to News Archive

          Share this Story

          Share via Facebook
          Share via TwitterShare via EmailPrint Friendly Version

          Other Recent Stories/ RSS

          Monday, May 22, 2017

          UC Hastings Students Honored for Public Interest Service

          The UC Hastings community celebrates its inspiring, tireless, and big-hearted students with a dedication to serve and help others in need.
          Tuesday, May 09, 2017

          Antitrust Law & American Rag: Larry Russ ’78 gives his advice on success in law and entrepreneurial ventures

          UC Hastings alumnus Larry Russ discusses the law, business, and making a plan for the future.
          Monday, May 01, 2017

          Thinkers & Doers: April 2017

          Legal Marketing Website -- The Nuclear Option -- A Festschrift for Prof. Miyazawa -- “Nobody’s going to copy something that’s going to kill people” -- One of the Frozen Chosen -- Wildfire Gig Economy -- and much more
          Monday, May 01, 2017

          UC Hastings Courtside: 3L Paul Jones works with Brooklyn Legal Services in New York City

          Paul Jones experiences real-life practice in Brooklyn, New York and the Kings County Housing Court through the Pro Bono Scholars Program.
          Thursday, April 20, 2017

          Legalized: Aaron Herzberg ’95 is at the forefront of California’s budding cannabis industry.

          2L Jeremy Schwartz, President of UC Hastings Law Students for Sensible Drug Policy, interviews the divorce attorney turned marijuana real estate entrepreneur and dispensary owner.
          Go to News Archive